VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment : cohort analysis of the Phase III VISTA study

• DIMOPOULOS MA

Journal

• J Clin Oncol

  J Clin Oncol 27 6086-6093, 2009

Details

• CRID: 1571698600708706560
• NII Article ID: 10030965988
• Data Source:
  • CiNii Articles